Patents by Inventor Monica Carmosino

Monica Carmosino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10149837
    Abstract: Object of the present invention is the use of selective agonists of beta-adrenergic type 3 receptors (BAR3) in the treatment of nephrogenic diabetes insipidus (NDI), in particular of X-linked nephrogenic diabetes insipidus (X-NDI).
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: December 11, 2018
    Assignees: UNIVERSITA' DEGLI STUDI DI BARI, UNIVERSITA' DEGLI STUDI DELLA BASILICATA, UNIVERSITA' DEGLI STUDI DI PISA
    Inventors: Maria Svelto, Giuseppe Procino, Monica Carmosino, Massimo Dal Monte, Paola Bagnoli
  • Publication number: 20170296516
    Abstract: Object of the present invention is the use of selective agonists of beta-adrenergic type 3 receptors (BAR3) in the treatment of nephrogenic diabetes insipidus (NDI), in particular of X-linked nephrogenic diabetes insipidus (X-NDI).
    Type: Application
    Filed: September 23, 2015
    Publication date: October 19, 2017
    Inventors: Maria SVELTO, Giuseppe PROCINO, Monica CARMOSINO, Massimo DAL MONTE, Paola BAGNOLI
  • Patent number: 8318771
    Abstract: Nephrogenic diabetes insipidus is treated with statins.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: November 27, 2012
    Assignee: Universita' Degli Studi di Bari
    Inventors: Giuseppe Procino, Maria Svelto, Giovanna Valenti, Monica Carmosino
  • Publication number: 20120029001
    Abstract: Nephrogenic diabetes insipidus is treated with statins.
    Type: Application
    Filed: July 30, 2010
    Publication date: February 2, 2012
    Applicant: UNIVERSITA' DEGLI STUDI DI BAR (Italian Nationality)
    Inventors: Giuseppe Procino, Maria Svelto, Giovanna Valenti, Monica Carmosino